Search research articles
Contact Us
Filters
Showing results (1-10 of 48) with videos related to
Page
of 5
Sort By:
Journal of Gastroenterology and Hepatology
|
December 19, 2014
"Gastric cytoprotection" is still relevant
Sandor Szabo
Inflammopharmacology
|
May 15, 2023
The post-COVID stress syndrome: from the three-stage stress response of Hans Selye to COVID-19
Sandor Szabo
Current Pharmaceutical Design
|
May 26, 2015
New molecules as drug candidates for the treatment of upper and lower GI tract ulcers
Sandor Szabo, Ganna Tolstanova
Inflammopharmacology
|
June 21, 2022
A closer look at endothelial injury-induced platelet hyperactivity and the use of aspirin in the treatment of COVID infection
Lenard M Lichtenberger, Sandor Szabo
Inflammopharmacology
|
September 11, 2024
On the origin of cysteamine-induced duodenal cytotoxicity and type II ferroptosis
John V Schloss, Sandor Szabo
World Journal of Gastroenterology
|
May 1, 2007
Protein and non-protein sulfhydryls and disulfides in gastric mucosa and liver after gastrotoxic chemicals and sucralfate: possible new targets of pharmacologic agents
Lajos Nagy, Miki Nagata, Sandor Szabo
Inflammopharmacology
|
March 28, 2023
Introduction to the 'long COVID' special issue
Sandor Szabo, Klara Gyires, Oksana Zayachkivska
Stress (Amsterdam, Netherlands)
|
August 1, 2012
The legacy of Hans Selye and the origins of stress research: a retrospective 75 years after his landmark brief "letter" to the editor# of nature
Sandor Szabo, Yvette Tache, Arpad Somogyi
Inflammopharmacology
|
March 25, 2023
What is really 'Long COVID'?
Sandor Szabo, Oksana Zayachkivska, Alamdar Hussain, et al.
Current Pharmaceutical Design
|
June 24, 2017
"Stress" is 80 Years Old: From Hans Selye Original Paper in 1936 to Recent Advances in GI Ulceration
Sandor Szabo, Masashi Yoshida, Janos Filakovszky, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 48) with videos related to
Sort By:
Page
of 5
Journal of Gastroenterology and Hepatology
|
December 19, 2014
"Gastric cytoprotection" is still relevant
Sandor Szabo
Inflammopharmacology
|
May 15, 2023
The post-COVID stress syndrome: from the three-stage stress response of Hans Selye to COVID-19
Sandor Szabo
Current Pharmaceutical Design
|
May 26, 2015
New molecules as drug candidates for the treatment of upper and lower GI tract ulcers
Sandor Szabo, Ganna Tolstanova
Inflammopharmacology
|
June 21, 2022
A closer look at endothelial injury-induced platelet hyperactivity and the use of aspirin in the treatment of COVID infection
Lenard M Lichtenberger, Sandor Szabo
Inflammopharmacology
|
September 11, 2024
On the origin of cysteamine-induced duodenal cytotoxicity and type II ferroptosis
John V Schloss, Sandor Szabo
World Journal of Gastroenterology
|
May 1, 2007
Protein and non-protein sulfhydryls and disulfides in gastric mucosa and liver after gastrotoxic chemicals and sucralfate: possible new targets of pharmacologic agents
Lajos Nagy, Miki Nagata, Sandor Szabo
Inflammopharmacology
|
March 28, 2023
Introduction to the 'long COVID' special issue
Sandor Szabo, Klara Gyires, Oksana Zayachkivska
Stress (Amsterdam, Netherlands)
|
August 1, 2012
The legacy of Hans Selye and the origins of stress research: a retrospective 75 years after his landmark brief "letter" to the editor# of nature
Sandor Szabo, Yvette Tache, Arpad Somogyi
Inflammopharmacology
|
March 25, 2023
What is really 'Long COVID'?
Sandor Szabo, Oksana Zayachkivska, Alamdar Hussain, et al.
Current Pharmaceutical Design
|
June 24, 2017
"Stress" is 80 Years Old: From Hans Selye Original Paper in 1936 to Recent Advances in GI Ulceration
Sandor Szabo, Masashi Yoshida, Janos Filakovszky, et al.
Page
of 5